These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 6222510)

  • 1. Structure of an anti-plasmin inhibitor, eckol, isolated from the brown alga Ecklonia kurome Okamura and inhibitory activities of its derivatives on plasma plasmin inhibitors.
    Fukuyama Y; Kodama M; Miura I; Kinzyo Z; Kido M; Mori H; Nakayama Y; Takahashi M
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):349-53. PubMed ID: 2525966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of age on in vitro plasmin generation in the presence of fibrin monomer.
    Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK
    Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen concentrations and functional activities and concentrations of plasmin inhibitors in plasma samples from normal subjects and patients with septic shock.
    Gallimore MJ; Aasen AO; Erichsen NS; Larsbraaten M; Lyngaas K; Amundsen E
    Thromb Res; 1980 Jun; 18(5):601-8. PubMed ID: 6158114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of alpha 2-plasmin inhibitor].
    Mimuro J; Aoki N
    Rinsho Byori; 1985 Feb; Spec No 61():97-105. PubMed ID: 2860263
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lysine- and arginyl-binding sites of plasminogen domains].
    Kudinov SA
    Ukr Biokhim Zh (1978); 1985; 57(5):23-35. PubMed ID: 2932824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parameters related to fibrinolysis and their meanings].
    Urano T; Suzuki Y
    Rinsho Byori; 2011 Jul; 59(7):703-8. PubMed ID: 21874797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmin inhibitors].
    Bumblite I-AD
    Gematol Transfuziol; 1992; 37(5-6):26-8. PubMed ID: 1478428
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephelometric determination of plasminogen and plasmin inhibitors in human plasma using fibrin suspension as a substrate.
    Saito Y; Takabayashi K; Tsukada T; Inada Y
    Thromb Res; 1983 Apr; 30(1):47-54. PubMed ID: 6222510
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.